Stacy Lindborg, Director at Brainstorm Cell Therapeutics, holds 48.23K shares in Brainstorm Cell Therapeutics (Ticker: BCLI), holds 264.17K shares in Imunon (Ticker: IMNN).

See the Hottest Stocks Based on Insider Trading >

Stacy Lindborg
Brainstorm Cell Therapeutics (BCLI)
Director

Ranked #83,842 out of 100,285 Corporate Insiders

Profitable Transactions

0 out of 2 Profitable Transactions

Average Return

-51.80%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

72.57%

IMNN

27.43%

BCLI

A breakdown of Stacy Lindborg's holdings

See the Top Stocks by Insiders

Insider Roles

Imunon
(IMNN)

President & CEO, Director

Brainstorm Cell Therapeutics
(BCLI)

Director

Roles that Stacy Lindborg holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Imunon
(IMNN)

Rating:Informative Buy

Date:Aug 16, 2024 - Today

Return:-21.10%

The most profitable trade made by Stacy Lindborg

See the Latest Stocks Traded by Insiders

Stacy Lindborg's Trading History

BCLI

Brainstorm Cell Therapeutics

Jan 03, 2025

Director

Uninformative Buy

―

$91.15K

IMNN

Imunon

Aug 16, 2024

President & CEO, Director

Informative Buy

24.50K

$241.18K

List of latest transactions for each holding click on a transaction to see Stacy Lindborg's performance on stock

See All Insider Trading from Today

Stacy Lindborg insider profile FAQ

What is the percentage of profitable transactions made by Stacy Lindborg?

The percentage of profitable transactions made by Stacy Lindborg is 0%.

What is the average return per transaction made by Stacy Lindborg?

The average return per transaction made by Stacy Lindborg is -51.80%.

What stocks does Stacy Lindborg hold?

Stacy Lindborg holds: BCLI, IMNN stocks.

What was Stacy Lindborg’s latest transaction?

Stacy Lindborg latest transaction was an Uninformative Buy of ―.

What was Stacy Lindborg's most profitable transaction?

Stacy Lindborg’s most profitable transaction was an Informative Buy of IMNN stock on August 16, 2024. The return on the trade was -21.10%.

What is Stacy Lindborg's role in Brainstorm Cell Therapeutics?

Stacy Lindborg's role in Brainstorm Cell Therapeutics is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Stacy Lindborg Insider Profile

Stacy Lindborg Brainstorm Cell Therapeutics (BCLI)Director